Expertise in
15
conditions

Dr. Larry C. Kilgore

Oncology
Office
1928 Alcoa Hwy Ste 127, 
Knoxville, TN 
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
Office
1928 Alcoa Hwy Ste 127, 
Knoxville, TN 

Overview

Larry Kilgore is an Oncologist practicing medicine in Knoxville, Tennessee.

Dr. Kilgore is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Ovarian Cancer, Ovarian Carcinosarcoma, and Ureteroscopy.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 6 clinical trials. Dr. Kilgore is currently accepting new patients.

Specialties

Oncology

Licenses

Obstetrics & Gynecology in AL

Hospital Affiliations

Blount Memorial Hospital
University Health System, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Office
1928 Alcoa Hwy Ste 127, Knoxville, TN 37920

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: August 19, 2022
Intervention Type: Drug
Study Drug: Prexasertib
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

9 Total Publications

A Cohort Study Exploring HPV Vaccination Beliefs Among Oral Health Providers: Broadening the Scope of Education and Administration.
A Cohort Study Exploring HPV Vaccination Beliefs Among Oral Health Providers: Broadening the Scope of Education and Administration.
Journal: Vaccines
Published: October 16, 2024
Similar Doctors
Expertise in
26
conditions
Dr. Haydar A. Frangoul
Hematology | Oncology
Expertise in
26
conditions
Dr. Haydar A. Frangoul
Hematology | Oncology
Referral may be required

TriStar Medical Group Children's Specialists - West Clinch Ave

2018 Clinch Ave, 
Knoxville, TN 
 (5.0 miles away)
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Haydar Frangoul is a Hematologist and an Oncologist practicing medicine in Knoxville, Tennessee. Dr. Frangoul is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Frangoul is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Univ. Breast Center

1926 Alcoa Hwy Ste 410, 
Knoxville, TN 
 (0.1 miles away)
865-305-8780
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Panella is an Oncologist practicing medicine in Knoxville, Tennessee. Dr. Panella is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Melanoma, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Panella is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

University Of Tennessee Medical Center

1924 Alcoa Hwy, 
Knoxville, TN 
 (4.6 miles away)
865-305-6740
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kristopher Kimball is an Oncologist practicing medicine in Knoxville, Tennessee. Dr. Kimball is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Bladder Reconstruction. Dr. Kimball is currently accepting new patients.

Frequently Asked Questions about Dr. Larry C. Kilgore

How do I make an appointment with Dr. Larry C. Kilgore?

You can book an appointment with Dr. Larry C. Kilgore by calling their office at 865-305-8787. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Larry C. Kilgore a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Larry C. Kilgore is classified as an Distinguished expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Larry C. Kilgore specialize in?

While Dr. Larry C. Kilgore is a Oncology, they have specific expertise in Endometrial Cancer, Desmoplastic Small Round Cell Tumor, and Ovarian Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Larry C. Kilgore participate in research or clinical trials?

Yes. Dr. Larry C. Kilgore has published 9 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Dr. Larry C. Kilgore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Larry C. Kilgore accept my insurance?

Dr. Larry C. Kilgore accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 865-305-8787 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kilgore's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 7 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile